From cancer medication to antibiotic

Antibiotic-resistant bacteria are increasingly the source of deadly infections. A team of scientists from the Technical University of Munich (TUM) and the Helmholtz Center for Infection Research (HZI) in Braunschweig have now modified an approved cancer drug to develop an active agent against multidrug-resistant pathogens. MRSA The methicillin-resistant Staphylococcus aureus (MRSA) is the source of severe and persistent… Read More »